A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Last updated: | August 2021 | |||||||||||||||||||||||
2 | |||||||||||||||||||||||||
3 | Study | Status | Description | Results available? | Source 1 | Source 2 | Source 3 | ||||||||||||||||||
4 | Fifth SMC cycle | Complete | A typical SMC round involves four cycles of SMC administration during the four months of the rainy season. This study, conducted in one district in Burkina Faso, pilots the addition of a fifth monthly cycle to the SMC round to assess its feasibility and impact on malaria incidence. | Results are available (see cell note). | Malaria Consortium, Research and impact report, 2019 | Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020 | Traore 2020 | ||||||||||||||||||
5 | Age eligibility | Complete | SMC is typically targeted at children aged 3–59 months, though coverage data suggests that it is often administered to children outside of this age range. This study, conducted in Chad, examines common barriers to accurately determining age eligibility and the feasibility of extending SMC administration to children aged 5-10 years. | Results are available (see cell note). | Malaria Consortium, Research and impact report, 2019 | Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020 | Malaria Consortium, 2021 | ||||||||||||||||||
6 | Vitamin A integration | Complete | This study, conducted in one LGA in Nigeria, pilots the integration of SMC administration and vitamin A distribution into one campaign. | Results are available (see cell note). | Malaria Consortium, Research and impact report, 2019 | Malaria Consortium, Co-implementing vitamin A supplementation with seasonal malaria chemoprevention: A pilot implementation study in Sokoto state, Nigeria | Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020 | ||||||||||||||||||
7 | Data accuracy | Complete | This study sought to assess how useful Health Management Information System (HMIS) data are for measuring the impact of SMC and other malaria control programs. It compared HMIS with data from outpatient registers at 14 health facilities in Massaguet district, Chad. | Results are available (see cell note). | Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020 | ||||||||||||||||||||
8 | IPC guideline adherence | Complete | Malaria Consortium, in partnership with national malaria programs and co-implementers, carried out a mixed-methods, multi-country study in Burkina Faso, Chad, and Nigeria to assess adherence by community distributors to IPC (infection prevention and control) guidelines. | Results are available. | Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020 | ||||||||||||||||||||
9 | Geospatial platform usability | In progress | Malaria Consortium, in collaboration with Akros, pilot tested Reveal, a geospatial platform, in one LGA in Sokoto state, Nigeria. | Data analysis is complete, and publication is in progress. | Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020 | Adesoro 2020 | |||||||||||||||||||
10 | Implementing SMC in Mozambique | In progress | Malaria Consortium is conducting a two-year pilot study of SMC in Mozambique. The first year of the study focused on assessing the feasibility and acceptability of implementing SMC in this context. | Research activities are ongoing. | Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020 | Wharton-Smith et al. 2021 | Malaria Consortium 2021 | ||||||||||||||||||
11 | Implementing SMC in Uganda | In progress | Malaria Consortium is implementing an SMC pilot in Karamoja, Uganda, with two treatment districts and one comparison district. | Research activities are ongoing. | Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020 | Malaria Consortium 2021 | |||||||||||||||||||
12 | Role model approach | In progress | The role model approach is a community-driven behavior change strategy that identifies existing strengths or solutions among individuals in a community, which are then shared with other community members to bring about positive changes in behavior. Malaria Consortium is exploring this approach to address the challenges associated with SPAQ administration in Burkina Faso, Chad and Togo, and to find existing, local solutions for improvement. | Research activities are ongoing. | Malaria Consortium 2021 | ||||||||||||||||||||
13 | Lead mothers | In progress | Lead Mothers (LMs) are female members of the community who conduct health promotion activities in Nigeria. Although LMs have been working on SMC campaigns for a number of years, the impact of their role on the SMC program has not been evaluated. In 2021/22, Malaria Consortium, with the National Malaria Elimination Programme in Nigeria, is conducting a study to assess and then optimize the role of Lead Mothers in SMC campaigns in Kano state, northern Nigeria. | Research activities are ongoing. | Synopsis to be published on Malaria Consortium's website shortly | ||||||||||||||||||||
14 | |||||||||||||||||||||||||
15 | |||||||||||||||||||||||||
16 | |||||||||||||||||||||||||
17 | |||||||||||||||||||||||||
18 | |||||||||||||||||||||||||
19 | |||||||||||||||||||||||||
20 | |||||||||||||||||||||||||
21 | |||||||||||||||||||||||||
22 | |||||||||||||||||||||||||
23 | |||||||||||||||||||||||||
24 | |||||||||||||||||||||||||
25 | |||||||||||||||||||||||||
26 | |||||||||||||||||||||||||
27 | |||||||||||||||||||||||||
28 | |||||||||||||||||||||||||
29 | |||||||||||||||||||||||||
30 | |||||||||||||||||||||||||
31 | |||||||||||||||||||||||||
32 | |||||||||||||||||||||||||
33 | |||||||||||||||||||||||||
34 | |||||||||||||||||||||||||
35 | |||||||||||||||||||||||||
36 | |||||||||||||||||||||||||
37 | |||||||||||||||||||||||||
38 | |||||||||||||||||||||||||
39 | |||||||||||||||||||||||||
40 | |||||||||||||||||||||||||
41 | |||||||||||||||||||||||||
42 | |||||||||||||||||||||||||
43 | |||||||||||||||||||||||||
44 | |||||||||||||||||||||||||
45 | |||||||||||||||||||||||||
46 | |||||||||||||||||||||||||
47 | |||||||||||||||||||||||||
48 | |||||||||||||||||||||||||
49 | |||||||||||||||||||||||||
50 | |||||||||||||||||||||||||
51 | |||||||||||||||||||||||||
52 | |||||||||||||||||||||||||
53 | |||||||||||||||||||||||||
54 | |||||||||||||||||||||||||
55 | |||||||||||||||||||||||||
56 | |||||||||||||||||||||||||
57 | |||||||||||||||||||||||||
58 | |||||||||||||||||||||||||
59 | |||||||||||||||||||||||||
60 | |||||||||||||||||||||||||
61 | |||||||||||||||||||||||||
62 | |||||||||||||||||||||||||
63 | |||||||||||||||||||||||||
64 | |||||||||||||||||||||||||
65 | |||||||||||||||||||||||||
66 | |||||||||||||||||||||||||
67 | |||||||||||||||||||||||||
68 | |||||||||||||||||||||||||
69 | |||||||||||||||||||||||||
70 | |||||||||||||||||||||||||
71 | |||||||||||||||||||||||||
72 | |||||||||||||||||||||||||
73 | |||||||||||||||||||||||||
74 | |||||||||||||||||||||||||
75 | |||||||||||||||||||||||||
76 | |||||||||||||||||||||||||
77 | |||||||||||||||||||||||||
78 | |||||||||||||||||||||||||
79 | |||||||||||||||||||||||||
80 | |||||||||||||||||||||||||
81 | |||||||||||||||||||||||||
82 | |||||||||||||||||||||||||
83 | |||||||||||||||||||||||||
84 | |||||||||||||||||||||||||
85 | |||||||||||||||||||||||||
86 | |||||||||||||||||||||||||
87 | |||||||||||||||||||||||||
88 | |||||||||||||||||||||||||
89 | |||||||||||||||||||||||||
90 | |||||||||||||||||||||||||
91 | |||||||||||||||||||||||||
92 | |||||||||||||||||||||||||
93 | |||||||||||||||||||||||||
94 | |||||||||||||||||||||||||
95 | |||||||||||||||||||||||||
96 | |||||||||||||||||||||||||
97 | |||||||||||||||||||||||||
98 | |||||||||||||||||||||||||
99 | |||||||||||||||||||||||||
100 |